87 related articles for article (PubMed ID: 11747002)
1. Reproducibility of T2* blood volume and vascular tortuosity maps in cerebral gliomas.
Jackson A; Kassner A; Zhu XP; Li KL
J Magn Reson Imaging; 2001 Nov; 14(5):510-6. PubMed ID: 11747002
[TBL] [Abstract][Full Text] [Related]
2. Abnormalities in the recirculation phase of contrast agent bolus passage in cerebral gliomas: comparison with relative blood volume and tumor grade.
Jackson A; Kassner A; Annesley-Williams D; Reid H; Zhu XP; Li KL
AJNR Am J Neuroradiol; 2002 Jan; 23(1):7-14. PubMed ID: 11827869
[TBL] [Abstract][Full Text] [Related]
3. Pharmacokinetic analysis of glioma compartments with dynamic Gd-DTPA-enhanced magnetic resonance imaging.
Lüdemann L; Hamm B; Zimmer C
Magn Reson Imaging; 2000 Dec; 18(10):1201-14. PubMed ID: 11167040
[TBL] [Abstract][Full Text] [Related]
4. Estimate of vascular permeability and cerebral blood volume using Gd-DTPA contrast enhancement and dynamic T2*-weighted MRI.
Cao Y; Shen Z; Chenevert TL; Ewing JR
J Magn Reson Imaging; 2006 Aug; 24(2):288-96. PubMed ID: 16795091
[TBL] [Abstract][Full Text] [Related]
5. Quantification of endothelial permeability, leakage space, and blood volume in brain tumors using combined T1 and T2* contrast-enhanced dynamic MR imaging.
Zhu XP; Li KL; Kamaly-Asl ID; Checkley DR; Tessier JJ; Waterton JC; Jackson A
J Magn Reson Imaging; 2000 Jun; 11(6):575-85. PubMed ID: 10862055
[TBL] [Abstract][Full Text] [Related]
6. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
[TBL] [Abstract][Full Text] [Related]
7. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
[TBL] [Abstract][Full Text] [Related]
8. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
9. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
Magn Reson Imaging; 2005 Oct; 23(8):833-41. PubMed ID: 16275421
[TBL] [Abstract][Full Text] [Related]
10. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
Warmuth C; Gunther M; Zimmer C
Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
[TBL] [Abstract][Full Text] [Related]
11. Perfusion MR imaging: moving forward.
Sorensen AG
Radiology; 2008 Nov; 249(2):416-7. PubMed ID: 18936306
[No Abstract] [Full Text] [Related]
12. Correlation of immunohistologic and perfusion vascular parameters with MR contrast enhancement using image-guided biopsy specimens in gliomas.
Jain R; Narang J; Gutierrez J; Schultz LR; Scarpace L; Rosenblum M; Mikkelsen T; Rock JP
Acad Radiol; 2011 Aug; 18(8):955-62. PubMed ID: 21718954
[TBL] [Abstract][Full Text] [Related]
13. Comparison of BOLD cerebrovascular reactivity mapping and DSC MR perfusion imaging for prediction of neurovascular uncoupling potential in brain tumors.
Pillai JJ; Zacà D
Technol Cancer Res Treat; 2012 Aug; 11(4):361-74. PubMed ID: 22376130
[TBL] [Abstract][Full Text] [Related]
14. Inclusion or exclusion of intratumoral vessels in relative cerebral blood volume characterization in low-grade gliomas: does it make a difference?
Caseiras GB; Thornton JS; Yousry T; Benton C; Rees J; Waldman AD; Jäger HR
AJNR Am J Neuroradiol; 2008 Jun; 29(6):1140-1. PubMed ID: 18388221
[TBL] [Abstract][Full Text] [Related]
15. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.
Shin JH; Lee HK; Kwun BD; Kim JS; Kang W; Choi CG; Suh DC
AJR Am J Roentgenol; 2002 Sep; 179(3):783-9. PubMed ID: 12185064
[TBL] [Abstract][Full Text] [Related]
16. Prognostic vascular imaging biomarkers in high-grade gliomas: tumor permeability as an adjunct to blood volume estimates.
Jain R; Narang J; Griffith B; Bagher-Ebadian H; Scarpace L; Mikkelsen T; Littenberg B; Schultz LR
Acad Radiol; 2013 Apr; 20(4):478-85. PubMed ID: 23498990
[TBL] [Abstract][Full Text] [Related]
17. Quantification of cerebral tumour blood flow and permeability with T1-weighted dynamic contrast enhanced MRI: a feasibility study.
Dujardin MI; Sourbron SP; Chaskis C; Verellen D; Stadnik T; de Mey J; Luypaert R
J Neuroradiol; 2012 Oct; 39(4):227-35. PubMed ID: 21840059
[TBL] [Abstract][Full Text] [Related]
18. Comparison of gadopentetate dimeglumine and albumin-(Gd-DTPA)30 for microvessel characterization in an intracranial glioma model.
Ostrowitzki S; Fick J; Roberts TP; Wendland MF; Aldape KD; Mann JS; Israel MA; Brasch RC
J Magn Reson Imaging; 1998; 8(4):799-806. PubMed ID: 9702880
[TBL] [Abstract][Full Text] [Related]
19. The assessment of immature microvascular density in brain gliomas with dynamic contrast-enhanced magnetic resonance imaging.
Jia ZZ; Gu HM; Zhou XJ; Shi JL; Li MD; Zhou GF; Wu XH
Eur J Radiol; 2015 Sep; 84(9):1805-9. PubMed ID: 26066470
[TBL] [Abstract][Full Text] [Related]
20. Abnormalities of the contrast re-circulation phase in cerebral tumors demonstrated using dynamic susceptibility contrast-enhanced imaging: a possible marker of vascular tortuosity.
Kassner A; Annesley DJ; Zhu XP; Li KL; Kamaly-Asl ID; Watson Y; Jackson A
J Magn Reson Imaging; 2000 Feb; 11(2):103-13. PubMed ID: 10713941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
